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Introduction
This consensus statement reflects the deliberations of an in-
ternational group of stakeholders with a range of expertise in
public involvement and engagement (PI&E) relating to data-
intensive health research. It sets out eight key principles to es-
tablish a secure role for PI&E in and with the research commu-
nity internationally and ensure best practice in its execution.
Our aim is to promote culture change and societal benefits
through ensuring a socially responsible trajectory for innova-
tions in this field.
Our key premise is that the public should not be char-
acterised as a problem to be overcome but a key part of
the solution to establish socially beneficial data-intensive
health research for all.
Data-intensive health research
Data-intensive health research is a fast moving field as ever
more data are generated, new computational abilities are de-
veloped, a wider variety of data and data types are linked, and
novel applications in health care are fostered. (Box 1)
Internationally, the significant interest in research uses of
routinely collected health-relevant data has led to the creation
of data infrastructures in different jurisdictions which facilitate
and undertake data-intensive health research including Health
Data Research UK (HDR UK), in the U.K., the Western Aus-
tralia Data Linkage System and Population Health Research
Network in Australia, and Population Data BC in Canada.
These developments have led to calls for a new social con-
tract between health related science and the public [1,2] and
the relationship between science and society has come un-
der increasing scrutiny. Recent highly publicised controversies
over data use in research, such as with national data records
systems in England [2] and Australia [3] suggest that public
acceptance cannot be assumed. Yet, public support is needed
to foster innovation and research: such research needs to re-
flect public values and interests if it is to gain such support.
Publics1 then hold a key position as both generators and recip-
ients of the potential benefits of health related data science.
There is now broad recognition of the value of public
knowledge and expertise in relation to science, technology and
medicine [4, 5] and PI&E is increasingly part of the contem-
porary landscape of health research and health care innovation
[6, 7]. However, while scientists, funders and policy-makers in-
creasingly emphasise the importance of dialogue, their efforts
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Box 1. What is Data-Intensive Health Research?
The term data-intensive health research refers to forms of health research which are conducted through the linkage and
analysis of data. These data can take many forms and be derived from diverse sources.
Some examples of the types of data which are used in this research include:
• Data from patient records;
• Administrative data (e.g. from social care, housing or education);
• Data from registries;
• Genomic data (e.g. from biobanks);
• Data generated through use of apps;
• Social media data.
Research may use data from a single source or link data from multiple sources together. These data are de-identified.
This research is conducted for a range of purposes including:
• Clinical decision support;
• Monitoring drug safety;
• Developing predictive models;
• Examining connections between social or behavioural factors and health outcomes;
• Audit of services.
have often been criticised for being tokenistic or cosmetic [8,
9]. Although some consensus is emerging around the impor-
tance of PI&E, commitments and practices are varied. The
emergence of data intensive research, and the social contract
upon which it relies, demands that we move beyond rhetorical
commitments and engage anew with clearly stated principles
to build PI&E into data-intensive health research at all levels.
Renewal is required if data-intensive health research is to de-
velop in socially acceptable and ethically robust ways [10-13].
Characterising public involvement and engage-
ment
PI&E is an important mechanism for engendering and sus-
taining the necessary social licence for data-intensive health
research, and members of the public have diverse perspectives
and insights which can and should play an important role in
shaping research infrastructures, processes and applications.
The processes and purposes of PI&E are also diverse. These
range from raising awareness of current research, consulting
members of the public on their views about health research,
working in partnership, to empowering members of the public
to play a role in shaping current or future research or gov-
ernance practices [12]. Some examples of the range of ap-
proaches which can be used in PI&E are summarised in Box
2.
PI&E relating to data-intensive health research takes place
at many different scales, including:
• Wide-scale public conversations about uses or potential
uses of data in health research;
• PI&E to inform or co-design the development of policies
or governance practices relating to uses of data in health
research;
• Engagement or involvement of members of the public in
governance decisions about data access and use;
• Engagement or involvement of members of the public at
different phases in particular research projects;
• Analysing and disseminating the results of research using
data in ways which will support improvements in health
care and systems.
While the methods used may not vary greatly from PI&E
with other types of research, or other policy areas, there
are particular features of data-intensive health research which
make PI&E in this area worthy of special consideration. These
are addressed in detail below.
Developing the consensus statement
A workshop was held in Manchester, UK in April 2017.
This was organised by the Public Engagement research
team of the Farr Institute of Health Informatics Research
(www.farrinstitute.org), and chaired by Simon Denegri from
INVOLVE. The workshop was attended by 31 international
participants, identified from literature searches, networks and
recommendations. They represented a range of practical ex-
perience of PI&E and/or research into public attitudes around
data use/linkage. Consensus workshop participants included
practitioners, policy stakeholders and academics (principally
social scientists). In addition, representatives of each of the
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Box 1. What is Data-Intensive Health Research?
Public Involvement and Engagement (PI&E) can serve a variety of purposes and take diverse approaches. These approaches
can be categorised as: Awareness Raising, Consultation and Empowerment and, while not mutually exclusive, lead to a
variety of different methods being used. Awareness Raising involves information being disseminated to the public. Through
consultation information (including ideas, preferences or concerns) is sought from the public. Empowerment can occur
through developing skills, capacities and social capital and enhancing democracy [12].
Some examples of methods which have been used in PI&E relating to data-intensive health research are shown here:
Figure 1: Adapted from Davidson et al 2013 [12]
four Farr Institute Public Panels also participated. Workshop
participants came from the U.K., Ireland, Australia, Canada,
Finland and the Netherlands.
The format comprised plenary and small group discussions
when participants moved between four tables, each facilitated
by a member of the Farr Institute Public Engagement research
team. Key points were summarised on flipcharts and post-
it notes. Each of the small group discussions were recorded
and transcribed by members of the research team and de-
tailed notes were taken of plenary discussions. A short report
of the day was circulated to all participants. A small team
(MA; MT; CP; SCB) from the Farr Institute drafted an initial
consensus statement based on the day’s discussions and con-
clusions. This was circulated for comment by the workshop
attendees, a small number of invitees who had not been able
to attend the workshop and the four Farr Institute Public Pan-
els. The statement went through further iterations in response
to comments. All authors have agreed this final version.
The following section sets out why we consider PI&E to re-
quire special consideration in relation to data-intensive health
research. The statement then delineates key principles that
should underpin PI&E in data-intensive health research and
drive its implementation.
Public Involvement and Engagement
in Data-Intensive Health Research
Requires Special Consideration
Data-intensive health research utilises data from large num-
bers of people, including whole populations. This presents
challenges about whom to engage and whether, or how, PI&E
should reach everyone whose data are used. Many other forms
of health-related research involve active research participation
from patients or publics, and often with smaller overall num-
bers: in these instances PI&E can be more easily targeted at
relevant patient or service user groups.
• Given the scale of data-intensive health research,
involving data from large numbers of people and
populations, PI&E is particularly important for
awareness raising and for enabling people to par-
ticipate in processes of research and governance.
In contrast with much other research, data scientists typi-
cally have no contact with those from whom data are derived,
creating distance between ‘science’ and ‘society’. Particular
effort is required to overcome this and for scientists to develop
an understanding of the context and implications of their re-
search.
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• PI&E is particularly important to bridge the gap
between data scientists and the people to whom
the data relates.
The data that are used in research relate to people’s lives,
yet members of the public may feel disconnected from such
information about them as they cannot usually see it, do not
know what it relates to, where it is or how it is used. PI&E
is a means for increasing public awareness of the data that
are collected, generating new forms of data (e.g. through citi-
zen science approaches), and engagement in the ways they are
used. This is important for ensuring transparency and also for
empowering members of the public to be involved in decisions
about how their data are used and/or shared.
• As well as bridging a gap between researchers and
the people to whom the data relates, PI&E can
also be a mechanism for bridging a gap between
members of the public and the data about them.
What is legally permissible is not necessarily the same as
what is publicly acceptable. As such PI&E has a role to play in
ensuring that current and future practices reflect public values
and interests, shaping governance in a dynamic and dialogic
way.
• Given that data are often used and linked without
individuals’ explicit consent, PI&E has an impor-
tant role to play in establishing a social licence for
current and future practices.
In many other forms of health-related research, PI&E is
essential in order to support specific research, for example as
a route to improving recruitment or ensuring consent is in-
formed through accessible materials. In data-intensive health
research, the rationale for PI&E is itself at a different scale,
dealing with wider social relations and key concepts such as
trustworthiness, transparency, fairness and empowerment.
• Data-intensive health research can promote and
enact PI&E to address wider science society
relations.
Key Principles for Public Involvement
and Engagement in Data-Intensive
Health Research
This statement is based on the understanding that the public
should not be characterised as a problem to be overcome but
a key part of the solution to establish socially beneficial data-
intensive health research for all. PI&E has a crucial role to
play in the fast-moving field of data-intensive health research.
To maximise its value and impact it is important to contin-
ually improve the scholarship and practice of PI&E in ways
that are innovative, inclusive and help secure a sustainable so-
cial licence or contract. To do so, this consensus statement
posits the following key principles which serve to underpin best
practice:
PI&E relating to data-intensive health research should:
1. Have institutional buy-in
In order to achieve meaningful impact there needs to be a
commitment to promote PI&E and to act on the findings. In-
stitutions need to go beyond rhetorical commitments and ges-
tures; this leads to a disconnected PI&E and a failure to close
the feedback loop. Given the many different scales at which
PI&E takes place and the range of impacts it can bring, institu-
tional buy-in has to occur at all levels and across many sectors,
including universities, research institutes, funding bodies and
governmental organisations. It is crucial that leadership and
governance fully embrace PI&E, recognising the value that it
brings and putting in place systems and processes to enable
PI&E to be impactful and meaningful. Achieving best practice
in PI&E therefore also requires institutional support to develop
strategy and skills amongst the research community.
2. Have clarity of purpose
The reasons for undertaking PI&E and the ways in which
this can effect change should be clearly articulated. This is
relevant for an overall PI&E strategy for an organisation, for
a programme of research or for an individual researcher or re-
search project. Given the diversity of purposes that PI&E can
serve, explicit statements about purpose are required and these
should be updated during the process of engagement if nec-
essary. Clarity of purpose is essential in order to set apposite
and realistic expectations and select appropriate approaches
or evaluation methods.
3. Be transparent
PI&E should be conducted with a high degree of trans-
parency both about the data-intensive health research under
consideration as well as about its own purpose and processes.
This requires openness and accountability to the public about
what is happening to data about them, how decisions are made
and the ways they can become involved.
4. Involve two-way communication
Two-way conversations enable members of the public to
be active participants and contributors or partners in involve-
ment and engagement in research related processes. This is a
key element that differentiates public engagement from public
facing communication strategies. Although the provision of
information has an important role in engagement, as aware-
ness raising and in the context of deliberation and dialogue,
informing alone should not be characterised as PI&E. Diversity
and disagreement are positive features essential for construc-
tive and uncensored dialogue. Consensus is not necessarily a
key outcome.
5. Be inclusive and accessible to broad publics
Members of the public are competent deliberators who
possess valuable expertise and insights relevant to data-
intensive health research and its governance. Incorporating
public perspectives adds real value and can substantially im-
prove research and governance processes. However, facilitators
4
Aitken, M et. al. / International Journal of Population Data Science (2019) 4:1:06
need to adapt their language and the format of events to en-
sure accessibility. Those involved in PI&E activities should be
supported to make the most of the engagement opportunities
offered and to freely and fully articulate their views. PI&E
should facilitate the participation of diverse groups and inter-
ests.
6. Be ongoing
PI&E should form part of an ongoing strategy rather than
relying on one-off events. It should start early on in the devel-
opment of research, governance and other relevant activities.
The fast paced field of data-intensive health research requires
PI&E to be adaptive to reflect and respond to changing con-
texts and practices. PI&E should also lead the way in inform-
ing research and governance practices as they evolve, in order
to ensure these are guided by public values and interests.
7. Be designed to produce impact
A success criterion of PI&E has to be identifiable impacts
or demonstrable change related to the overall purposes of the
engagement. PI&E should therefore be designed with consid-
eration of the potential mechanisms needed to enable change
and realise impact with appropriate feedback to participants
and wider publics. Change can occur in relation to the di-
rection or focus of PI&E as well as in relation to the project,
programme or policy to which it relates. PI&E should lead to
positive impacts not just for researchers, institutions or partic-
ular projects but also for public participants and wider society.
8. Be evaluated
PI&E with data-intensive health research is emerging as
an important area within the broader field of PI&E with
health care and with science. This field is continually evolving
through the development and evaluation of new approaches
and methods. Evaluation and critical reflexivity of practition-
ers are crucial to establishing good practice. Evaluation should
relate both to processes and outcomes and engage with differ-
ent perspectives, including those of public participants. This
is key to ensuring the success of particular approaches as well
as being vital to the continued development of the science of
PI&E itself.
Conclusion
We propose that these principles should guide approaches to
PI&E with data-intensive health research. They should inform
the design, implementation and evaluation of PI&E strategies
and activities2 and shape the mind-sets of researchers, funders
and other stakeholders. Adherence to these principles should
promote and sustain meaningful PI&E and secure the social
licence required to support data-intensive health research now
and in the future, with publics as partners not passive recip-
ients of such developments. This will give PI&E authenticity
which in turn increases its authority.
This consensus statement is intended to be used in a re-
flective way to guide practice as the field evolves. Through
doing so, this document is intended to remain relevant as the
field continues to move in new directions. We invite people to
reflect on this when discussing PI&E in data-intensive health
research and engage with us to promote best practice locally,
nationally and internationally.
Funding
This project was funded by The Farr Institute of Health In-
formatics Research. The Farr Institute was supported by
a 10-funder consortium: Arthritis Research UK, the British
Heart Foundation, Cancer Research UK, the Economic and
Social Research Council, the Engineering and Physical Sci-
ences Research Council, the Medical Research Council, the
National Institute of Health Research, the National Institute
for Social Care and Health Research (Welsh Assembly Gov-
ernment), the Chief Scientist Office (Scottish Government
Health Directorates), the Wellcome Trust, (MRC Grant No:
MR/M501633/2).
Contribution of Authors
SCB and SD conceived the idea for this project. MA and
MPT developed the plans for the consensus workshop. MA,
MPT, CP and SCB developed the materials to be used at
the consensus workshop, with input from LC, NKF, LH and
KHJ. SD chaired and facilitated the consensus workshop. MA,
MPT, CP and SCB co-facilitated the consensus workshop. All
authors participated in the discussions at the consensus work-
shop. MA and CP transcribed the consensus workshop discus-
2Generic PI&E guidance can be found in a range of existing toolkits and resources, including for example:
From the U.K.:
Centre for Public Engagement (NCCPE)’s website contains a range of resources which are helpful for planning, conducting and evaluating public
engagement activities: https://www.publicengagement.ac.uk/
The National Institute for Health Research (NIHR)’s INVOLVE website contains advice on involving members of the public in research: http:
//www.invo.org.uk/
Sciencewise Public Views Toolkit: http://www.sciencewise-erc.org.uk/cms/public-views-toolkit/
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The Health Research Board (HRB) website offers guidance on public and patient involvement in research: http://www.hrb.ie/funding/
funding-schemes/public-and-patient-involvement-in-research/
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